BSE filing, NSE: ORCHPHARMA. Summary written from the filing by ALFA Finder's alert engine.
Orchid Pharma Ltd: key numbers
- Share price
- ₹891.00
- Market cap
- ₹5,336 Cr
- Revenue (annual)
- ₹811.3 Cr
- Net profit (annual)
- ₹20.55 Cr
- P/E (TTM)
- 615.6×Sector 46.1×
- Promoter holding
- 74.45%+4.61% QoQ
- FII holding
- 0.93%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Orchid Pharma Ltd
All →Orchid Pharma Partnership
Orchid Pharma entered a licensing and supply agreement with Laboratorio Libra for Exblifep across nine Latin American markets. The partnership is expected to represent a potential opportunity of about USD 80 million over 10 years.
Orchid Pharma Fund Raise of ₹600 Cr
Orchid Pharma's board approved an enabling resolution to raise funds of up to ₹600 Crore through equity or debt securities via various permissible modes.
- Value
- ₹600.0 Cr
Orchid Pharma Other Announcement
The company submitted its quarterly shareholding pattern under Regulation 31(1)(b) for the quarter ended September 30, 2026.
Orchid Pharma Board Meeting Date
Orchid Pharma has scheduled a board meeting for October 20, 2026, to consider options for raising funds. The company will explore various suitable funding avenues.
Orchid Pharma Other Announcement
Orchid Pharma Ltd has filed its quarterly Shareholding Pattern, providing a routine update on promoter and public shareholding as mandated by SEBI regulations.
Orchid Pharma Annual General Meeting
Orchid Pharma held its 33rd Annual General Meeting on September 29, 2026, where shareholders considered and approved routine business resolutions and related party transactions.
Other board meeting date announcements
All →Jyoti CNC Automation Board Meeting Date
Jyoti CNC Automation Ltd will hold a board meeting on November 03, 2026, to approve standalone and consolidated financial results for the quarter ended September 30, 2026.
Generic Engineering Construction and Projects Board Meeting Date
Generic Engineering Construction and Projects Ltd scheduled a board meeting on November 3, 2026. The meeting will consider standalone and consolidated quarterly financial results.
Lemon Tree Hotels Board Meeting Date
Lemon Tree Hotels announced a board meeting on November 5, 2026, to consider and approve unaudited financial results for the quarter and half-year ended September 30, 2026.
Powerica Board Meeting Date
Powerica Ltd scheduled a board meeting for November 5, 2026, to consider and approve financial results for the quarter and half year ended September 30.
Mehta Securities Board Meeting Date
Mehta Securities has scheduled a board meeting on 6 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window stays closed from 1 October 2026 until 48 hours after results.
Mehta Integrated Finance Board Meeting Date
Mehta Integrated Finance scheduled a board meeting on November 6, 2026 to approve half-year results. The trading window remains closed until results are declared.